US 11124835
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted A61KA61K31/44A61P
Quick answer
US patent 11124835 (Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers) held by Transgenion—International Institute for Regenerative Translational Medicine GmbH expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Transgenion—International Institute for Regenerative Translational Medicine GmbH
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/44, A61P, A61P11/00